These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18591445)

  • 1. Letter by Höglund and Nilsson regarding article, "influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure".
    Höglund P; Nilsson LA
    Circulation; 2008 Jul; 118(1):e7; author reply e8. PubMed ID: 18591445
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by de Boer and van Veldhuisen regarding article, "Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)".
    de Boer RA; van Veldhuisen DJ
    Circulation; 2008 Jan; 117(1):e7; author reply e8. PubMed ID: 18172042
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter by Andreotti et al regarding article, "Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) study".
    Andreotti F; Coluzzi G; Crea F
    Circulation; 2007 Mar; 115(9):e313; author reply e314. PubMed ID: 17339559
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.
    Massie BM; Collins JF; Ammon SE; Armstrong PW; Cleland JG; Ezekowitz M; Jafri SM; Krol WF; O'Connor CM; Schulman KA; Teo K; Warren SR;
    Circulation; 2009 Mar; 119(12):1616-24. PubMed ID: 19289640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurohormonal regulation of cardiac ion channels in chronic heart failure.
    Kurokawa J; Abriel H
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):98-105. PubMed ID: 19597366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Dose-dependent" impact of recurrent cardiac events on mortality in patients with heart failure.
    Lee DS; Austin PC; Stukel TA; Alter DA; Chong A; Parker JD; Tu JV
    Am J Med; 2009 Feb; 122(2):162-169.e1. PubMed ID: 19100960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality in adult patients with congenital heart disease.
    Trojnarska O; Grajek S; Katarzyński S; Kramer L
    Cardiol J; 2009; 16(4):341-7. PubMed ID: 19653177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes does not affect ventricular repolarization and sudden cardiac death risk in patients with dilated cardiomyopathy.
    Vrtovec B; Fister M; Poglajen G; Starc V; Haddad F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S146-50. PubMed ID: 19250080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study.
    Anselmino M; De Ferrari GM; Massa R; Manca L; Tritto M; Molon G; Curnis A; Devecchi P; Sarzi Braga S; Bartesaghi G; Klersy C; Accardi F; Salerno-Uriarte JA;
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S214-8. PubMed ID: 19250099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter regarding the article by Katz et al, "Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure".
    Lundberg J; Weitzberg E
    Circulation; 2005 Aug; 112(6):e84; author reply e84. PubMed ID: 16087805
    [No Abstract]   [Full Text] [Related]  

  • 14. Getting the most out of life.
    Schwartzman D
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1167-8. PubMed ID: 18631267
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors.
    Ascenção R; Fortuna P; Reis I; Carneiro AV
    Rev Port Cardiol; 2008 Sep; 27(9):1169-87. PubMed ID: 19044179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.
    Jhund PS; Macintyre K; Simpson CR; Lewsey JD; Stewart S; Redpath A; Chalmers JW; Capewell S; McMurray JJ
    Circulation; 2009 Feb; 119(4):515-23. PubMed ID: 19153268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
    Anand IS; Carson P; Galle E; Song R; Boehmer J; Ghali JK; Jaski B; Lindenfeld J; O'Connor C; Steinberg JS; Leigh J; Yong P; Kosorok MR; Feldman AM; DeMets D; Bristow MR
    Circulation; 2009 Feb; 119(7):969-77. PubMed ID: 19204305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.